These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4008165)

  • 1. Particulate oral NMR contrast agents.
    Runge VM; Foster MA; Clanton JA; Smith FW; Lukehart CM; Hutchison JM; Mallard JR; Partain CL; James AE
    Int J Nucl Med Biol; 1985; 12(1):37-42. PubMed ID: 4008165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paramagnetic NMR contrast agents. Development and evaluation.
    Runge VM; Clanton JA; Foster MA; Smith FW; Lukehart CM; Jones MM; Partain CL; James AE
    Invest Radiol; 1984; 19(5):408-15. PubMed ID: 6439672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT.
    Low RN; Francis IR
    AJR Am J Roentgenol; 1997 Oct; 169(4):1051-9. PubMed ID: 9308464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Work in progress: potential oral and intravenous paramagnetic NMR contrast agents.
    Runge VM; Stewart RG; Clanton JA; Jones MM; Lukehart CM; Partain CL; James AE
    Radiology; 1983 Jun; 147(3):789-91. PubMed ID: 6844614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetite albumin suspension: a superparamagnetic oral MR contrast agent.
    Widder DJ; Edelman RR; Grief WL; Monda L
    AJR Am J Roentgenol; 1987 Oct; 149(4):839-43. PubMed ID: 3498337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear magnetic resonance contrast enhancement study of the gastrointestinal tract of rats and a human volunteer using nontoxic oral iron solutions.
    Wesbey GE; Brasch RC; Engelstad BL; Moss AA; Crooks LE; Brito AC
    Radiology; 1983 Oct; 149(1):175-80. PubMed ID: 6611926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation of radiographically detectable gastrointestinal contrast agents for magnetic resonance imaging: effects of a barium sulfate additive on MR contrast agent effectiveness.
    Rubin DL; Muller HH; Young SW
    Magn Reson Med; 1992 Jan; 23(1):154-65. PubMed ID: 1734177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro evaluation of alternative oral contrast agents for MRI of the gastrointestinal tract.
    Babos M; Schwarcz A; Randhawa MS; Marton B; Kardos L; Palkó A
    Eur J Radiol; 2008 Jan; 65(1):133-9. PubMed ID: 17485189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymeric gastrointestinal MR contrast agents.
    Tilcock C; Unger EC; Ahkong QF; Fritz T; Koenig SH; Brown RD
    J Magn Reson Imaging; 1991; 1(4):463-7. PubMed ID: 1790369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast enhancement of the gastrointestinal tract on MR images using intravenous gadolinium-DTPA.
    Mirowitz SA
    Abdom Imaging; 1993; 18(3):215-9. PubMed ID: 8508075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR imaging of the gastrointestinal tract: value of Gd-DTPA.
    Laniado M; Kornmesser W; Hamm B; Clauss W; Weinmann HJ; Felix R
    AJR Am J Roentgenol; 1988 Apr; 150(4):817-21. PubMed ID: 3126628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gadolinium-DTPA as an oral contrast medium for MR tomography of the abdomen].
    Krahe T; Dölken W; Lackner K; Houselog M; Habscheid W; Clauss W
    Rofo; 1990 Aug; 153(2):167-73. PubMed ID: 2168072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous in vivo visualization and localization of solid oral dosage forms in the rat gastrointestinal tract by magnetic resonance imaging (MRI).
    Christmann V; Rosenberg J; Seega J; Lehr CM
    Pharm Res; 1997 Aug; 14(8):1066-72. PubMed ID: 9279890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Euterpe Olerácea (Açaí) as an alternative oral contrast agent in MRI of the gastrointestinal system: preliminary results.
    Córdova-Fraga T; de Araujo DB; Sanchez TA; Elias J; Carneiro AA; Brandt-Oliveira R; Sosa M; Baffa O
    Magn Reson Imaging; 2004 Apr; 22(3):389-93. PubMed ID: 15062934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gadolinium-DTPA as an oral contrast medium in magnetic resonance tomography].
    Kaminsky S; Laniado M; Gogoll M; Kornmesser W; Clauss W; Felix R
    Radiol Diagn (Berl); 1989; 30(5):541-8. PubMed ID: 2587719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gadolinium zeolite as an oral contrast agent for magnetic resonance imaging.
    Young SW; Qing F; Rubin D; Balkus KJ; Engel JS; Lang J; Dow WC; Mutch JD; Miller RA
    J Magn Reson Imaging; 1995; 5(5):499-508. PubMed ID: 8574032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barium sulfate suspension as a negative oral MRI contrast agent: in vitro and human optimization studies.
    Li KC; Tart RP; Fitzsimmons JR; Storm BL; Mao J; Rolfes RJ
    Magn Reson Imaging; 1991; 9(2):141-50. PubMed ID: 2034046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI evaluation of potential gastrointestinal contrast media.
    Wan X; Wedeking P; Tweedle MF
    Magn Reson Imaging; 1995; 13(2):215-8. PubMed ID: 7739362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferric ammonium citrate as a positive bowel contrast agent for MR imaging of the upper abdomen. Safety and diagnostic efficacy.
    Kivelitz D; Gehl HB; Heuck A; Krahe T; Taupitz M; Lodemann KP; Hamm B
    Acta Radiol; 1999 Jul; 40(4):429-35. PubMed ID: 10394873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A potentially artifact-free oral contrast agent for gastrointestinal MRI.
    Liebig T; Stoupis C; Ros PR; Ballinger JR; Briggs RW
    Magn Reson Med; 1993 Nov; 30(5):646-9. PubMed ID: 8259066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.